PROBLEM IDENTIFICATION: This study aims to evaluate the effects of self-management interventions (SMIs) for cancer survivors who completed primary treatment. . LITERATURE SEARCH: Using PubMed, EMBASE, CINAHL®, PsycINFO®, and Cochrane Central Register of Controlled Trails (CENTRAL), the authors conducted a systematic search of randomized, controlled trials published in English from database conception through June 2016. . DATA EVALUATION: The meta-analysis was conducted with Cochrane Review Manager, version 5.3, and R program, version 3.3.1. . SYNTHESIS: 12 studies were systematically reviewed for self-management content, mode of delivery, session composition, and type of self-management skills used. Then, a meta-analysis of nine randomized, controlled trials involving 2,804 participants was conducted comparing SMIs with usual care, attention control, and a waitlist group. Qualitative synthesis showed that (a) the major study population was comprised of breast cancer survivors; (b) SMIs focused on medical/behavioral and emotional management; (c) the most common mode of delivery was web-based; and (d) the most frequently evaluated outcomes were depression, self-efficacy, and health-related quality of life (HRQOL). Quantitative results demonstrated a significant medium effect on HRQOL and a large effect on fatigue of borderline significance. The effects on anxiety, depression, and self-efficacy were not statistically significant. . CONCLUSIONS: SMIs had a significant medium effect on HRQOL for cancer survivors post-treatment, but the findings should be interpreted with caution because of substantial heterogeneity. In addition, the small number of studies limits conclusions. . IMPLICATIONS FOR NURSING: SMI as a nursing intervention for improving HRQOL of cancer survivors can be recommended, but more research should be undertaken to determine the most effective SMI format in terms of type, mode of delivery, and session composition.
PROBLEM IDENTIFICATION: This study aims to evaluate the effects of self-management interventions (SMIs) for cancer survivors who completed primary treatment. . LITERATURE SEARCH: Using PubMed, EMBASE, CINAHL®, PsycINFO®, and Cochrane Central Register of Controlled Trails (CENTRAL), the authors conducted a systematic search of randomized, controlled trials published in English from database conception through June 2016. . DATA EVALUATION: The meta-analysis was conducted with Cochrane Review Manager, version 5.3, and R program, version 3.3.1. . SYNTHESIS: 12 studies were systematically reviewed for self-management content, mode of delivery, session composition, and type of self-management skills used. Then, a meta-analysis of nine randomized, controlled trials involving 2,804 participants was conducted comparing SMIs with usual care, attention control, and a waitlist group. Qualitative synthesis showed that (a) the major study population was comprised of breast cancer survivors; (b) SMIs focused on medical/behavioral and emotional management; (c) the most common mode of delivery was web-based; and (d) the most frequently evaluated outcomes were depression, self-efficacy, and health-related quality of life (HRQOL). Quantitative results demonstrated a significant medium effect on HRQOL and a large effect on fatigue of borderline significance. The effects on anxiety, depression, and self-efficacy were not statistically significant. . CONCLUSIONS: SMIs had a significant medium effect on HRQOL for cancer survivors post-treatment, but the findings should be interpreted with caution because of substantial heterogeneity. In addition, the small number of studies limits conclusions. . IMPLICATIONS FOR NURSING: SMI as a nursing intervention for improving HRQOL of cancer survivors can be recommended, but more research should be undertaken to determine the most effective SMI format in terms of type, mode of delivery, and session composition.
Entities:
Keywords:
cancer survivors; meta-analysis; self-management; systematic review
Authors: Marieke van Leeuwen; Jacobien M Kieffer; Teresa E Young; Maria Antonietta Annunziata; Volker Arndt; Juan Ignacio Arraras; Didier Autran; Hira Bani Hani; Manas Chakrabarti; Olivier Chinot; Juhee Cho; Rene Aloisio da Costa Vieira; Anne-Sophie Darlington; Philip R Debruyne; Linda Dirven; Daniela Doege; Yannick Eller; Martin Eichler; Nanna Fridriksdottir; Ioannis Gioulbasanis; Eva Hammerlid; Mieke van Hemelrijck; Silke Hermann; Olga Husson; Michael Jefford; Christoffer Johansen; Trille Kristina Kjaer; Meropi Kontogianni; Pernilla Lagergren; Emma Lidington; Karolina Lisy; Ofir Morag; Andy Nordin; Amal S H Al Omari; Andrea Pace; Silvia De Padova; Duska Petranovia; Monica Pinto; John Ramage; Elke Rammant; Jaap Reijneveld; Samantha Serpentini; Sam Sodergren; Vassilios Vassiliou; Irma Verdonck-de Leeuw; Ingvild Vistad; Teresa Young; Neil K Aaronson; Lonneke V van de Poll-Franse Journal: J Cancer Surviv Date: 2022-01-27 Impact factor: 4.442
Authors: Marco Di Nitto; Fabio Sollazzo; Valentina Biagioli; Gianluca Pucciarelli; Francesco Torino; Rosaria Alvaro; Ercole Vellone Journal: Support Care Cancer Date: 2022-05-31 Impact factor: 3.359
Authors: Xia Luo; Yuzhen Chen; Jing Chen; Yue Zhang; Mingfang Li; Chenxia Xiong; Jun Yan Journal: Support Care Cancer Date: 2021-09-24 Impact factor: 3.603
Authors: Doris Howell; Deborah K Mayer; Richard Fielding; Manuela Eicher; Irma M Verdonck-de Leeuw; Christoffer Johansen; Enrique Soto-Perez-de-Celis; Claire Foster; Raymond Chan; Catherine M Alfano; Shawna V Hudson; Michael Jefford; Wendy W T Lam; Victoria Loerzel; Gabriella Pravettoni; Elke Rammant; Lidia Schapira; Kevin D Stein; Bogda Koczwara Journal: J Natl Cancer Inst Date: 2021-05-04 Impact factor: 13.506